SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Medical Properties Trust, Inc. (MPW) , 前瞻盈利收益率 2.13%. PEG 0.83 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
- VALUE (100/100, 通过) — PEG ≤ 1.0 — Peter Lynch 低估标准 (0.83); 分析师目标价暗示上行空间 (+67.9%).
- 前瞻市盈率 46.9
- PEG 比率 0.83 — 低于1.0表明股票相对于其盈利增长率被低估（Peter Lynch 标准）。
- 分析师共识目标价 $9.00 (+67.9% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 46/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
✓
健康
100/100
Debt-to-Equity & liquidity
→ Health
估值概览 — MPW
估值倍数
P/E (TTM)0.0
前瞻 P/E46.9
PEG 比率0.83
前瞻 PEG0.83
P/B 比率0.00
P/S 比率3.31
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.33
前瞻 EPS（预估）$0.11
每股账面价值$0.00
每股营收$1.62
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
Forward Earnings Yield2.13%
股息收益率0.00%
分析师目标价$9.00 (+67.9%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$0.86 |
$541.14M |
$225.05M |
41.6% |
| 2017 |
$0.82 |
$704.75M |
$289.79M |
41.1% |
| 2018 |
$2.78 |
$784.52M |
$1.02B |
129.6% |
| 2019 |
$0.87 |
$854.2M |
$374.68M |
43.9% |
| 2020 |
$0.81 |
$1.25B |
$431.45M |
34.5% |
| 2021 |
$1.11 |
$1.54B |
$656.02M |
42.5% |
| 2022 |
$1.50 |
$1.54B |
$902.6M |
58.5% |
| 2023 |
$-0.93 |
$871.8M |
$-556.48M |
-63.8% |
| 2024 |
$-3.86 |
$995.55M |
$-2.41B |
-242.2% |
| 2025 |
$-0.33 |
$972.02M |
$-198.7M |
-20.4% |
